Clinical Trials on Norovirus Infection

Total 60511 results

WCCT Global
Vaxart

Completed

Evaluation of Infectivity and Illness of Norwalk GI.1 Virus Lot 001-09NV in the Human Challenge Model

Norovirus Infection

United States
Vaxart

Completed

Safety & Immunogenicity Study of Ad5 Based Oral Norovirus Vaccines (VXA-NVV-103)

Norovirus Infection

United States
Takeda

Completed

Norovirus Bivalent-Vaccine Efficacy Study

Prevention From Norovirus Infection

United States
Romark Laboratories L.C.

Completed

Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children

Rotavirus Infection | Norovirus Infection | Adenoviridae Infection
Takeda

Completed

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Children

Norovirus

Finland, Panama, Colombia
Takeda

Completed

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population

Norovirus

United States
LigoCyte Pharmaceuticals, Inc.

Completed

Phase 1 Norwalk Vaccine Study

Norovirus

United States
Takeda

Completed

Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults

Norovirus Prevention

United States
Takeda

Completed

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine (NOR-107)

Healthy Volunteers | Norovirus, Prevention

Belgium
Takeda

Completed

Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine

Healthy Participants | Norovirus

United States
Takeda

Completed

Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults

Healthy Volunteers | Norovirus

Belgium, United States
Chinese University of Hong Kong

Unknown

Identification of Host Factors of Norovirus Infections in Mini-Gut Model

Gastrointestinal Infection

China
Icon Genetics GmbH
University Hospital, Ghent

Completed

Recombinant, Bivalent, Norovirus Vaccine Study

Norovirus

Belgium
Children's Hospital Medical Center, Cincinnati
Mothers' Milk Bank Northeast

Terminated

Human Breastmilk in Young Children With Norovirus Infection of the Gut

Norovirus Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

New Challenge Pool of Norwalk Virus Inoculum

Gastroenteritis Norovirus

United States
Vaxart

Active, not recruiting

A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers

Norovirus Infections

United States
Vaxart

Completed

Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine (VXA-NVV-104)

Norovirus Infections

United States
Vaxart

Completed

A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based Tablet Norovirus Vaccine (VXA-G1.1-NN) Administered to Healthy Adult Volunteers ((VXA-G1-1-NN))

Norovirus Infections

United States
Vaxart

Completed

Immunogenicity & Safety Study of Adenovirus Type 5 (AD5) Based Oral Norovirus Vaccines (VXA-NVV-105)

Norovirus Infections

United States
Children's Hospital Medical Center, Cincinnati
LigoCyte Pharmaceuticals, Inc.

Completed

Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1) (CIN-002)

Norovirus Infections

United States
Vaxart

Completed

Norovirus Challenge Study (G1-1 Challenge)

Norovirus Infections

United States
National Vaccine and Serum Institute, China
Zhengzhou University; Lanzhou Institute of Biological Products Co., Ltd; Beijing...

Recruiting

Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha)

Norwalk Gastroenteritis | Norovirus Infections

China
National Vaccine and Serum Institute, China
Zhengzhou University; Lanzhou Institute of Biological Products Co., Ltd; Beijing...

Completed

A Clinical Trial to Evaluate the Safety and Immunogenicity of Norovirus Bivalent Vaccine

Norwalk Gastroenteritis | Norovirus Infections

China
National Vaccine and Serum Institute, China
Lanzhou Institute of Biological Products Co., Ltd

Not yet recruiting

Phase III Clinical Trial to Evaluate the Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula Polymorpha)

Norwalk Gastroenteritis | Norovirus Infections
National Institute of Allergy and Infectious Diseases...

Completed

Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies

Gastroenteritis Norovirus

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Norovirus Challenge Model

Gastroenteritis Norovirus

United States
Vaxart

Completed

Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine

Norovirus Gastroenteritis

United States
Vaxart

Completed

Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers

Norovirus Gastroenteritis

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1)

Gastroenteritis Norovirus

United States
National Institute of Allergy and Infectious Diseases...

Completed

NNITS-Nitazoxanide for Norovirus in Transplant Patients Study

Gastroenteritis Norovirus

United States
ModernaTX, Inc.

Active, not recruiting

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 49 Years of Age and 60 to 80 Years of Age.

Norovirus Acute Gastroenteritis

United States
Region Zealand

Completed

Admission Pattern Among Children With Gastro-intestinal Infections Before and During the Covid-19 Pandemic

Gastroenteritis | Infectious Disease | Dehydration in Children | COVID-19 Pandemic | Norovirus Infections | Rota Virus Gastroenteritis

Denmark
University of Zurich

Completed

Secondary Lactose Intolerance Due to Chronic Norovirus Infection

Chronic Diarrhea

Switzerland
Kirby Institute

Not yet recruiting

PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised. (PATH)

Invasive Fungal Infections | Infection, Bacterial | Infection, Fungal | Injection Site Infection | Infection, Soft Tissue | Invasive Bacterial Infection
Taipei Medical University WanFang Hospital

Unknown

Prevalence of Occult HBV Infection Among Anti-HBc Alone Group in Northern Taiwan

HBV Coinfection

Taiwan
Hospices Civils de Lyon
Exeliom Biosciences

Not yet recruiting

Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients (LIVEDIFF)

Clostridioides Difficile Infection | Recurrent Infection

France
National Institute of Allergy and Infectious Diseases...

Completed

Gene Expression in HIV and Tuberculosis Co-infection

Tuberculosis

United States
Jun Zhang
National Natural Science Foundation of China; Merck Sharp & Dohme LLC

Completed

A Cohort Study of Congenital Cytomegalovirus Infection Among Pregnant Women and Their Newborns in China

Congenital Cytomegalovirus Infection | Cytomegalovirus Infection Reactivation

China
Fundacion para la Investigacion Biomedica del Hospital...
Instituto de Salud Carlos III

Completed

Education vs Education Plus Intervention in HIV/HCV Diagnosis (DRIVE 03) (DRIVE)

HIV Infection | HCV Coinfection

Spain
Johns Hopkins Bloomberg School of Public Health

Completed

Etiology, Prevention and Treatment of Neonatal Infections in the Community

Infectious Disease | Bacterial Infection

Bangladesh
Mayo Clinic
Ortho-McNeil, Inc.

Completed

The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection

Staphylococcal Infection | Staphylococcus Aureus Prosthetic Joint Infection

United States
Pfizer

Completed

Post-Authorization Study Evaluating Safety Of Tigecycline (HORUS)

Intra-Abdominal Infections | Skin Disease, Infectious | Soft Tissues Infections
University of Washington
University of Nairobi; Kenyatta National Hospital; Kenya Medical Research Institute

Completed

Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation

HIV Infections | Helminthiasis

Kenya
The University of Hong Kong

Recruiting

Emergency PWAS in Respiratory Infectious Disease

Pneumonia | Sepsis | Bacterial Infections | Viral Infections | Fungal Infections | Mycobacterium Infection | Mixed Infection | Infection of Uncertain Aetiology

China
National Taiwan University Hospital

Recruiting

HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy

Hepatitis C Virus Infection | Hepatitis C Virus Infection, Response to Therapy of | Human Immunodeficiency Virus (HIV) Coinfection

Taiwan
Dr. Olivier Borens

Unknown

CERAMENT™|G - Bone Healing and Re-infection Prophylaxis

Osteomyelitis

Switzerland
University of Washington
La Clinique des Maladies Infectieuses, Centre Hospitalier National Universitaire...

Completed

Nutritional Support for HIV-Tuberculosis Co-infected Adults in Senegal, West Africa

HIV and Tuberculosis Co-infection
University Hospital, Strasbourg, France

Recruiting

Infections With Enterobacteria Producing Carbapenemases at the University Hospitals of Strasbourg (CARBA)

Nfections, Enterobacterial

France
Hillel Yaffe Medical Center

Completed

Effects of Viral and Bacterial Co-infections in Otherwise Healthy Children Hospitalized in Pediatric Department

Coinfection
Hospices Civils de Lyon

Completed

Staphylococcus Lugdunensis Prosthetic Joint Infection

Staphylococcal Infections | Prosthetic Joint Infection

France

Clinical Trials on Norovirus Infection

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations